High-CBD Cannabis Vapor Reduced Opioid Reward and Self-Administration in Female Rats Without Causing Harm

High-CBD whole-plant extract (WPE) vapor prevented morphine-induced conditioned place preference and reinstatement. WPE reduced fentanyl self-administration in rats with and without neuropathic pain. WPE showed modest efficacy against cold allodynia in nerve-injured rats. Chronic exposure did not affect lung tissue, cognition, social behavior, or estrous cycle. WPE vapor had no reinforcing properties.

Comprehensive preclinical analysis in female rats including conditioned place preference, fentanyl self-administration, neuropathic pain models (spared nerve injury), cognitive and social behavior tests, lung histology, and estrous cycle monitoring.

Most cannabis and opioid research has been done in male animals. This study fills a critical gap by showing that high-CBD cannabis vapor can reduce opioid reward and self-administration in females specifically, which matters because chronic pain is more prevalent in women.

The combination of reducing opioid reward, having a robust safety profile, and lacking abuse potential makes high-CBD cannabis vapor an intriguing candidate for opioid use disorder research. The fact that it reduced fentanyl self-administration even in rats with neuropathic pain is particularly relevant to the opioid crisis.

Animal study in female rats only. Modest analgesic effect against neuropathic pain. Cannot directly extrapolate vapor doses to human vaping. Short-term exposure only. Single cannabis extract may not represent all products.